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Abstract A method for the simultaneous determination of
caffeine and aspartame in various diet supplements and non-
alcoholic beverages is presented. The analytes were ana-
lysed by high-performance liquid chromatography coupled
to a charged aerosol detector (Corona CAD) and ultraviolet-
diode array detector (UV-DAD) simultaneously connected
in series. The method was validated using a Thermo Hyper-
sil Gold-C18 column packed with 5 μm shell particles
(150×4.6 mm) and acetonitrile–water (15/85% v/v) mobile
phase at a flow rate of 1.00 mL/min. The elaborated method
was validated for linearity, precision and accuracy. The
rapid HPLC–CAD–UV-DAD technique is suitable for quan-
tifying caffeine and aspartame in the range of 0.25–75 μg/mL
in diet supplements and non-alcoholic beverages. The limit of
detection for caffeine and aspartame was 62 and 43 ng/mL for
Corona CAD and 31 and 30 ng/mL for UV-DAD detector,
respectively. Each analyte calibration curve had a correlation
coefficient of at least 0.999 and was linear in the defined
range. The accuracies of CAD and UV-DAD detection were
all acceptable, with the mean value of 100% for aspartame and
98.3% for caffeine. Precision values ranged from 0.09% to
1.12%. The work has demonstrated that charged aerosol
detector can be successfully used in a rapid screening technique
for biologically active substances in non-alcoholic beverages
and diet supplements.
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Introduction
Food additives are strongly required by the modern food
technologies, which try to fulfill consumers’ demands for
variety, choice and convenience. These substances are used
in food to maintain its nutritive quality, enhance its keeping
quality and make it attractive or to aid in its processing,
packaging or storage. Among them, caffeine and aspartame
are widely used throughout the world.
Caffeine is one of a group of stimulants called methyl-
xanthine or xanthine that occurs naturally in some plants.
Products containing caffeine such as coffee, tea, soft drinks
and chocolate are used and enjoyed by many people
throughout the world. Besides, natural occurrence, caffeine
is also used as a food additive regulated by the Federal Food
and Drug Administration. Food and beverage manufacturers
are legally obliged to list caffeine on their products’ label
only when caffeine has been added. However, when caffeine
is naturally present in other ingredients used in the produc-
tion process need not be on the label. Caffeine can also be
found listed as an active ingredient in some stimulants, cold
remedies and various pain killers (Pawełczyk 1986).
This methylxanthine exhibits a number of biological
effects resulting from its diuretic and stimulant properties.
Some sensitive individuals experience side effects such as
insomnia, headaches, irritability and nervousness when con-
suming caffeine; therefore, it is recommended to limit caffeine
consumption (Pohler 2010; Wierzejska and Jarosz 2003).
Aspartame (L-alpha-aspartyl-L-phenylalanine methyl
ester) is a low-calorie sweetener used to sweeten a wide
variety of low-calorie foods and reduce calorie foods and
beverages, including low-calorie tabletop sweeteners. Upon
digestion, aspartame breaks down into three components
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(aspartic acid, phenylalanine and methanol), which are
then absorbed into the blood and used in normal body
processes. Neither aspartame nor its components accu-
mulate in the body. These components are used in the
body in the same ways as when they are derived from
common foods (Butchko et al. 2002; Magnuson et al.
2007).
Although aspartame can be safely consumed by most
healthy individuals, it has long been recognised that excessive
intake of phenylalanine, one of the constituent amino acids of
aspartame, can pose a hazard to individuals suffering from an
inherited metabolic disorder called phenylketonuria (Butchko
et al. 2002; Magnuson et al. 2007). For this reason, all foods
containing aspartame must be indicated on the label for the
presence of phenylalanine.
Currently, aspartame is consumed by over 200 million
people around the world and is found in more than 6,000
products including carbonated soft drinks, powdered soft
drinks, chewing gum, confections, gelatins, dessert mixes,
puddings and fillings, frozen desserts, yogurt, tabletop
sweeteners and some pharmaceuticals such as vitamins
and sugar-free cough drops (European Parliament and
Council Directive 94/35/EC 2011). The Food and Drug
Administration, the Joint Expert Committee on Food Addi-
tives (JECFA) of the World Health Organization, the Scien-
tific Committee for Food of the European Community and
regulatory agencies in more than 100 countries have
reviewed aspartame and found it safe for use (Butchko
et al. 2002; Magnuson et al. 2007).
Low-calorie sweeteners provide consumers with many
benefits, both psychological and physiological. Health pro-
fessionals and consumers believe low-calorie sweeteners are
effective for the following purposes: weight maintenance,
weight reduction, management of diabetes, reduction of
dental caries and reduction in the risks associated with
obesity (Butchko et al. 2002).
High-performance liquid chromatography (HPLC) has
been the most popular choice for the determination of addi-
tives (Wasik et al. 2007; Zygler et al. 2011; 2009); however,
other analytical methods have also been applied in their
analysis (Bergamo et al. 2011; Chen and Wang 2001; Zhu
et al. 2005) but the method using HPLC–Corona charged
aerosol detector (CAD) has not been reported up-to-date.
The Corona CAD is a new type of detector introduced for
HPLC applications and has recently become widely used
(Błażewicz et al. 2010; Eom et al. 2010; Kou et al. 2009;
Lísa et al. 2007; Nováková et al. 2009; Schönherr et al.
2009; Takahashi et al. 2008; Vervoort et al. 2008).
The detector Corona CAD measures a physical property
of analyte and responds to almost all non-volatile species,
independently of their nature and spectral or physico-
chemical properties. The eluent from the HPLC column is
nebulized with nitrogen and the droplets are dried to remove
the mobile phase, producing analyte particles. A sec-
ondary stream of nitrogen becomes positively charged
as it passes a high-voltage corona wire. This charge
transfers difusionally to the opposing stream of analyte
particles. The amount of charge acquired is directly
proportional to particle size. The charge is then trans-
ferred to a collector where it is measured by a highly
sensitive electrometer, generating a signal in direct
proportion to the quantity of analyte present (Corona
CAD 2011). It has been reported that Corona CAD can
provide greater sensitivity, wider linear response range and
better precision than other aerosol-based detectors such as
ELSD (Eom et al. 2010; Takahashi et al. 2008; Vervoort
et al. 2008). Moreover, Corona CAD is quite user-friendly
since it does not require any optimization of operating
parameters; therefore, it can be operated by any chromatog-
rapher without significant additional training (Schönherr
et al. 2009; Corona CAD 2011).
The purpose of this work was to propose a new methodol-
ogy for simultaneous determination of aspartame and caffeine
by Corona CAD and ultraviolet-diode array detector (UV-
DAD). This new method could be applied to the analysis of




All experiments were performed on an HPLC Ultimate 3000
system (Dionex, Germering, Germany) consisting of: a qua-
ternary pump, an autosampler and a column heater. A
Corona CAD instrument (ESA, Chelmsford, MA, USA)
was placed in series after the UV/DAD detector (Ultimate
3000, Dionex). Data processing was carried out with Chro-
meleon 6.8 software (Dionex). Nitrogen gas flow rate was
Table 1 Chromatographic conditions applied for the determination of
aspartame and caffeine
Column C18 (150×4.6 mm; 5.0 μm)
Mobile phase Acetonitrile/water (15:85 v/v)
Flow rate 1 mL/min
Injection volume 10 μl
Temperature 30 °C
Detector UV-DAD λ0210 nm
Detector Corona CAD Range 20 pA
filter: medium
nitrogen pressure: 35 psi
CAD charged aerosol detector, UV-DAD ultraviolet-diode array
detector
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regulated automatically and monitored by the CAD device
and it was supplied by nitrogen generator Sirocco-5 (Schmi-
dlin-DBS, Switzerland), regulated at 35 psi. Response range
was set to 20 pA full scale. Medium filter was applied.
Chromatographic analysis was carried out at 30 °C. Sam-
ples were separated on a Thermo Hypersil (Thermo Fisher
Scientific, Waltham, MA, USA) C18 column packed with
5 μm shell particles (150×4.6 mm) and acetonitrile–water
(15/85% v/v) mobile phase at a flow rate of 1.00 mL/min.
Particular chromatographic conditions are presented in
Table 1. UV signal at 210 nm was recorded on the DAD
using an acquisition rate of 10 points per second (Hertz).
Total time of analysis amounted to 10 min.
Chemicals, Reagents and Standards
The chemicals used were of analytical reagent grade and all
aqueous solutions were prepared using with ultra pure water
(18.2 MΩ/cm) from a Milli-Q system (Millipore, MA,
USA). HPLC-grade acetonitrile was obtained from J.T.
Baker (Malinckrodt Baker B.V., Holland). Aspartame was
obtained from Supelco (Bellefonte, USA) and caffeine from
Fluka Analytical (China). Standards were made by dissolv-
ing 0.025 g of each individual analyte in an ultra pure water
(aspartame) or methanol/water (50/50 v/v) mixture in sepa-
rate 100-mL volumetric flasks. These solutions were further
successively diluted with ultra pure water to obtain the
Table 2 Characteristics of the analysed products
Products codes Details
Soft drinks
A Cola drink, carbonated, produced in UE
A* Sugar-free light cola drink, contains aspartame, carbonated, produced in UE
A** Sugar-free cola drink, contains aspartame, carbonated, produced in UE
B 5 mg caffeine/100 mL, contains aspartame, non-carbonated, produced in UE
C 32 mg caffeine/100 mL, non-carbonated, produced in UE
C* 32 mg caffeine/100 mL, non-carbonated, produced in UE
D 10 mg caffeine/100 mL, cola drink, carbonated, produced in Poland
D* 12 mg caffeine/100 mL, contains aspartame, sugar-free light cola drink, carbonated, produced in Poland
D** 12 mg caffeine/100 mL, contains aspartame, sugar-free cola drink, carbonated, produced in UE
E 10 mg caffeine/100 mL, carbonated, produced in Poland
Energy drinks
F 30 mg caffeine/100 mL, carbonated, produced in Austria
G 35 mg caffeine/100 mL, carbonated, produced in Poland
H 32 mg caffeine/100 mL, contains aspartame, carbonated, sugar free, produced in Poland
I 56 mg caffeine/100 mL, carbonated, produced in UE
J 32 mg caffeine/100 mL, carbonated, produced in Austria
J* 32 mg caffeine/100 mL, contains aspartame, carbonated, sugar free, produced in Austria
K 174 mg caffeine/100 mL, non-carbonated, produced in Poland
E* 32 mg caffeine/100 mL, carbonated, produced in Poland
E** 32 mg caffeine/100 mL, carbonated, produced in Poland
Diet supplements
L Contains aspartame, soluble tablets, produced in Poland
M Contains aspartame, soluble tablets, produced in Poland
N Contains aspartame, soluble tablets, produced in Poland
O Contains aspartame, soluble tablets, produced in Poland
P Contains aspartame, soluble tablets, produced in Poland
R Contains aspartame, soluble tablets, produced in Poland
S Contains aspartame, powder in sachets, produced in Poland
T Contains aspartame, powder in sachets, produced in Poland
Tabletop sweetener
U Contains aspartame, produced in Poland
A–U signify different brands of products
* and ** different kinds of products of the same brand
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required concentrations. All solutions were stored in a cool,
dark place when not in use. The samples were stored for no
more than 14 days.
Sample Preparation
Nineteen commercially available non-alcoholic beverages,
including nine energy drinks, ten soft drinks and eight diet
supplements and a tabletop sweetener were randomly
obtained from the local market in Gdansk (Poland). The
soft and energy drinks codes were A–E and F–E**, respec-
tively. The letters signify different brands of products,
whereas the asterisks mark different kinds of products of
the same brand. In general, the purchased products represent
a variety of beverages which contain caffeine and/or aspar-
tame. Detailed characteristics of the analysed samples are
presented in Table 2. Each of the 114 analytical subsamples
analysed were injected in triplicate.
Samples of non-carbonated beverages were diluted,
filtered and applied directly. The carbonated drink sam-
ples were degassed in a laboratory shaker bath for
90 min (in room temperature) and diluted with ultra-
pure water as required. A 1-mL volume of cola drinks
was directly diluted by deionized water to a 25-mL
volumetric flask, whereas other products were diluted
tenfold before HPLC analysis. In case of solid samples,
an accurately weighed amount of 1 g of finely ground
and homogenised diet supplements and tabletop sweet-
ener was dissolved in ultra pure water in 100-mL vol-
umetric flask. Solid samples solutions were also diluted
tenfold before HPLC analysis. All the final solutions
were filtered through 0.45-μm filters prior to analysis.
Validation of the Method
The quantitative analysis was done by HPLC with analysis
conditions mentioned above. The data concerning method
validation are summarised in Table 3.
The linearity of the detector response was determined by
the square correlation coefficients of the calibration curves
generated by six repeated injections of standard solutions at
12 concentration levels in the range of 0.15–75 μg/mL or
0.25–75 μg/mL (Table 3). The calibration curves were
obtained by plotting concentration (in micrograms per mil-
liliter) against peak area. Although it is known that Corona
CAD response is nonlinear at a range of four orders of



















Aspartame/UV-DAD 0.15–75 0.9998 y0−0.021+0.264x 35 101 0.09 0.20 0.03 0.09
70 99.6 0.22 0.50
140 99.9 0.22 0.50
Aspartame/Corona CAD 0.25–75 0.9998 y0−0.047+1.021x 35 103 0.86 1.66 0.04 0.13
70 101 1.02 1.70
140 99.8 0.22 0.62
Caffeine/UV-DAD 0.10–75 0.9999 y00.0815+0.952x 150 100 1.12 2.01 0.03 0.09
300 98.1 0.30 0.83
600 96.1 0.31 0.49
Caffeine/Corona CAD 0.25–75 0.9987 y0−0.539+0.498x 150 98.8 0.78 3.02 0.06 0.19
300 97.5 0.74 2.67
600 98.6 0.41 1.78
CAD charged aerosol detector, UV-DAD ultraviolet-diode array detector, RSD relative standard deviation, LOD limit of detection, LOQ limit of
quatification
Table 4 Aspartame content in diet supplements and table sweetener
Product code n Tablet/sachet
weight (g)
Aspartame content
in 1 tablet/sachet (mg)
UV-DAD Corona CAD
L 12 3.95 27.7±0.32 28.2±0.44
M 12 4.52 23.1±0.43 22.4±1.10
N 15 4.20 7.86±0.27 7.58±1.05
O 12 3.96 23.3±0.64 23.5±0.62
P 12 4.02 22.6±1.90 23.9±0.14
R 12 4.52 16.9±1.02 15.7±0.72
S 9 3.89 7.00±0.22 5.51±0.06
T 9 1.99 1.93±0.13 1.44±0.00
U 9 0.05 19.4±0.55 16.6±0.28
CAD charged aerosol detector, UV-DAD ultraviolet-diode array detec-
tor, n number of analytical subsamples multiplied by number of injec-
tions (three)
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magnitude, its signal is nearly linear in the smaller
ranges (Błażewicz et al. 2010; Corona CAD 2011).
Responses obtained in the examined range (Table 3) were
expressed by a linear equation y0ax+b with good r2 deter-
mination coefficient values. The estimation of the detection
and quantitation limits was done based on the calibration
curve, using 3 SD/b and 10 SD/b (SD is the standard
deviation of the curve and b is the slope of the curve)
(Table 3).
Repeatability was assessed using three concentrations
covering the specified range for the procedure. The preci-
sion was calculated from three consecutive injections for
each concentration and the observed RSD ranged from
0.09% to 1.12% (Table 3). Intermediate precision was
calculated for 2 days.
Recoveries were determined by standard addition
method, i.e. by spiking a soft drink and a diet supplement
with known amounts of aspartame and caffeine (Table 3).
The accuracy of the recovery for aspartame and caffeine
added to a soft drink and a diet supplement was evaluated at
three levels, i.e. standard concentrations values were as
follows: 35, 70 and 140 μg/mL for aspartame and 150,
300 and 600 μg/mL for caffeine. The mean recoveries for
aspartame from each run were in the range of 99.8–103%
for Corona CAD and 99.6–101% for UV-DAD, whereas for
caffeine these, were between 97.5% and 98.8% for Corona
CAD and 96.1–100.4% for UV-DAD.
Results and Discussion
In the current study, the identification and determination of
aspartame and caffeine in diet supplements and non-
alcoholic beverages by means of HPLC–UV-DAD and
HPLC–Corona CAD are presented. The analytical method-
ology revealed good linearity, sensitivity, exactitude and
precision (Table 3). All samples were analysed according
to the experimental conditions (Table 1). The results
concerning diet supplements are summarised in Table 4
and non-alcoholic beverages in Table 5. The aspartame
and caffeine concentrations in the samples are characterised
by arithmetic mean value for wet weight basis and the
corresponding SD.
The results demonstrated in Tables 4 and 5 reveal a good
agreement between those determined by these two methods,
which indicates that Corona CAD would be a beneficial
alternative to UV-DAD for the separation and determination
of these substances. The average aspartame concentration in
diet supplements was in the range of 1.93 and 27.7 mg per
tablet (sachet) (Table 4). The lowest amount was determined
Table 5 Aspartame and caffeine concentrations in the analysed beverages
Product code n Aspartame (mg/100 mL) Caffeine (mg/100 mL) Caffeine declared (mg/100 mL)
UV-DAD Corona CAD UV-DAD Corona CAD
A 9 ND ND 10.8±1.09 7.57±0.85 –
A* 12 10.8±0.53 10.1±0.42 12.6±0.22 10.1±0.78 –
A** 9 6.23±0.73 5.54±0.39 9.86±0.43 7.22±0.36 –
B 15 0.87±0.03 0.67±0.10 4.60±0.15 3.87±0.31 5.00
C 9 ND ND 30.7±0.66 25.5±0.52 32.0
C* 9 ND ND 31.7±0.33 26.5±0.45 32.0
D 9 ND ND 10.4±0.22 7.43±0.55 10.0
D* 21 27.0±7.03 26.4±4.51 12.0±0.14 8.76±0.74 12.0
D** 9 58.6±2.51 53.3±0.79 13.4±0.79 9.31±0.29 12.0
E 9 ND ND 11.0±0.67 6.97±0.19 10.0
E* 9 ND ND 32.4±1.15 24.2±0.33 32.0
E** 9 ND ND 30.4±0.68 22.7±0.71 32.0
F 21 ND ND 28.7±0.65 23.8±0.58 30.0
G 21 ND ND 36.6±2.98 25.0±1.71 35.0
H 21 7.12±1.01 5.92±0.14 31.2±0.52 28.0±0.91 32.0
I 9 ND ND 55.0±0.61 46.3±1.18 56.0
J 9 ND ND 31.5±0.44 24.5±0.88 32.0
J* 21 10.4±1.80 9.21±2.45 30.6±1.16 26.5±2.01 32.0
K 9 ND ND 163±5.37 161±0.95 174
CAD charged aerosol detector, UV-DAD ultraviolet-diode array detector, ND not determined, n number of analytical subsamples multiplied by
number of injections (three)
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in the diet supplement recommended for children over
4 years old (product T), whereas the highest in the product
designed for students and people having problems with
concentration and memory (product L) (Table 4). Aver-
age aspartame concentration in tabletop sweetener was de-
termined between 16.6 mg (Corona CAD) and 19.4
mg/tablet/sachet (UV-DAD). Among soft drinks, the highest
average aspartame concentration was found in a product D
(cola drink), i.e. 58.6 mg/100 mL (UV-DAD) or 53.3
mg/100 mL (Corona CAD). Sugar-free energy drinks
contained aspartame between 7.12 and 10 mg/100 mL
(UV-DAD) or 5.92–9.21 mg/100 mL (Corona CAD).
According to Majewska (2008), aspartame content in two
types of tabletop sweeteners was in the range of 172 and
374 mg/g, which is comparable to our results. However,
Cantarelli et al. (2009) determined much lower levels of this
Fig. 1 Chromatograms of the
energy drinks samples “F”,
“G”, “H” and “J”. a UV-DAD
(210 nm); b Corona CAD.
Thermo Hypersil (Thermo
Fisher Scientific, Waltham, MA,
USA) C18 column packed
with 5 μm shell particles
(150×4.6 mm); mobile phase:
acetonitrile–water (15/85% v/v),
flow rate of 1.00 mL/min
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additive in tabletop sweeteners. Sękalska (2007) determined
aspartame in a popular diet cola drink, i.e. 58.6 mg/100 mL.
Similar levels of aspartame in soft drinks were found by
Wróbel and Wróbel (1997) and Gibbs et al. (1996).
The acceptable daily intake (ADI) value for aspartame
determined by JECFA is 0–40 mg/kg body mass (up to
2,800 mg/day for 70 kg man/woman) (Aspartame 2011).
Maximum daily intake of aspartame with the analysed sup-
plements is much lower than the ADI, and therefore, the
exposure to exceed the acceptable daily intake of this sweet-
ener is very small. The greatest value of the exposure (2.5%)
was recorded in the case of a product “O”, which according
to the manufacturer can be consumed up to three times a
day. On the other hand, the exposure through consumption
of the product “L” (dosage—two times per day), which
contained the highest concentration of aspartame, amounted
to 1.98%. Consumption of 250 mL of energy drinks on
average supplies human organism with 0.78% of ADI;
however, consumption of 250 mL of product “D” gives
5.5% of ADI dose for aspartame.
Caffeine was found in all the analysed soft and energy
drinks (Table 5). The highest caffeine concentration,
163 mg/100 mL (UV-DAD), was determined in an energy
drink (product K)—one of the newest products on Polish
market that constitutes a condensed form of conventional
energy drinks. Other energy drinks contained this substance
at the level oscillating around 30 mg/100 mL, whereas cola
drinks around 10 mg/100 mL. The lowest amount of
caffeine was found in soft drink “B”, 3.87 mg/100 mL
(Corona CAD). The results concerning caffeine presented
in this study are generally comparable to the data reported
by Armenta et al. (2005), Lucena et al. (2005) and Aranda
and Morlock (2000).
In assessing consumer exposure to caffeine, a specific
reference value should be used, i.e. a maximum daily dose
for an adult set by Polish Pharmacopoeia, which is amount-
ing to 1.5 g (Pharmacopeia 2008). The assessment of expo-
sure to caffeine in soft drinks has shown that the
consumption of 250 mL of the analysed products resulted
in the greatest exposure in case of the product “K” (27%)
and lowest in the case of the product “B” (0.71%). This
evaluation is very important as there are cases of fatal
caffeine intoxication (Holmgren et al. 2004; Kerrigan and
Lindsey 2005). However, susceptibility to poisoning
through exposure to caffeine cannot be unambiguously
determined due to very large individual variation, age, type
of ingested diet, medications or even smoking.
Figure 1a, b illustrates the results of HPLC analysis with
UV-DAD and Corona CAD detection, respectively, for the
exemplary samples of energy drinks. As can be observed,
aspartame and caffeine could be determined in two cases,
samples “H” and “J”, which is in agreement with the pro-
ducer declaration on the label, and in two samples “F” and
“G”, in which only caffeine was found. Therefore, it can be
concluded that this method is able to determine simulta-
neously aspartame and caffeine in real food samples so it
can be used for the routine analysis in control laboratories.
What’s more, in each of the samples analysed which have
been declared to contain aspartame and caffeine, these
substances were determined.
Conclusions
The HPLC–Corona CAD method with UV detection offers
high accuracy, good repeatability and reproducibility and a
relative short analysis time for quantification of aspartame
and caffeine in food samples. The simple mobile phase and
the isocratic elution yielded low detection limits and good
resolution within a minimum analysis time of 10 min. As the
results of real sample analysis are very satisfactory, this
method can be used for the routine analysis of aspartame
and caffeine in drinks and diet supplements. The develop-
ment of better tools for analysis of bioactive constituents in
food products that could be hazardous to human health will
continue to be important because all such activities will
ultimately contribute to the overall quality and safety of
food.
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